REGINALD EBIRIM: Open Payments
NPI 1396702957 · NEW LONDON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 14 payments from 6 companies in 2025. Trend: 2023 $344 · 2024 $510 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $111 |
| Exact Sciences Corporation | 3 | $69 |
| Lilly USA, LLC | 3 | $66 |
| PFIZER INC. | 3 | $59 |
| Amgen Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $32 |
Products named: Vemlidy, The Cologuard Plus Collection Kit, MOUNJARO, OTEZLA, PAXLOVID, ZEPBOUND, PREVNAR 20, UBRELVY.
Industry payments across WI — which companies pay providers there.
